{"DataElement":{"publicId":"2755610","version":"1","preferredName":"American College of Surgeons Oncology Group Person Inclusion Clinical Trial Eligibility Criteria Type","preferredDefinition":"the elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial of a person who receives medical attention, care, or treatment in a clinical trials cooperative group supported by NCI whose primary goal is to evaluate surgical therapies in the management of patients with malignant solid tumors.","longName":"ACOSOG_PER_INC_CT_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2755581","version":"1","preferredName":"American College of Surgeons Oncology Group Person Inclusion Clinical Trial Eligibility Criteria","preferredDefinition":"information relating to the elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial of a person who receives medical attention, care, or treatment in a clinical trials cooperative group supported by NCI whose primary goal is to evaluate surgical therapies in the management of patients with malignant solid tumors.","longName":"ACOSOG_PER_INCL_CTEC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2755579","version":"1","preferredName":"American College of Surgeons Oncology Group Person","preferredDefinition":"The American College of Surgeons Oncology Group (ACOSOG) is a cooperative group sponsored by the NCI whose primary goal is to evaluate surgical therapies in the management of patients with malignant solid tumors. The ACOSOG (Durham, NC) includes general and specialty surgeons, representatives of related oncologic disciplines and allied health professionals in academic medical centers and community practices throughout the US and foreign countries. The group is composed of the Administrative Coordinating Center and the Statistics and Data Coordinating. Both groups are based at the Duke Clinical Research Institute.:Person; a human being.","longName":"C19712:C25190","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"American College of Surgeons Oncology Group","conceptCode":"C19712","definition":"A cooperative group sponsored by the NCI whose primary goal is to evaluate surgical therapies in the management of patients with malignant solid tumors. The ACOSOG (Durham, NC) includes general and specialty surgeons, representatives of related oncologic disciplines and allied health professionals in academic medical centers and community practices throughout the US and foreign countries. The group is composed of the Administrative Coordinating Center and the Statistics and Data Coordinating. Both groups are based at the Duke Clinical Research Institute.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Person","conceptCode":"C25190","definition":"A human being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC3FFC2-8A3A-61F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"ONEDATA","dateModified":"2008-06-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2518229","version":"1","preferredName":"Inclusion Clinical Trial Eligibility Criteria","preferredDefinition":"The addition of somebody or something to, or the presence of somebody or something in, a group or mixture, particularly, a passive, usually temporary, product of cell activity within the cytoplasm or nucleus.:Elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.","longName":"C25532:C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inclusion Criteria","conceptCode":"C25532","definition":"Medical and/or social characteristics which are necessary for a subject to be allowed to participate in a clinical study, as outlined in the study protocol. Meeting inclusion criteria is not a sufficient condition for entry or recruitment of a subject into the study. Characteristics limiting the eligibility of a subject for the clinical study must be considered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CC96D39-08D4-6793-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-06","modifiedBy":"ONEDATA","dateModified":"2006-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC3FFC2-8A48-61F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2755609","version":"1","preferredName":"ACOSOG 1041 Inclusion Criteria Type","preferredDefinition":"the enumerated inclusion criteria for ACOSOG 1041.","longName":"ACOSOG 1041_INCL_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Within 3 months prior to study entry, patient must have a baseline left ventricular ejection fraction (LVEF) measured by MUGA scan >= 55","valueDescription":"Within 3 months prior to study entry, patient must have a baseline left ventricular ejection fraction (LVEF) measured by MUGA scan >= 55","ValueMeaning":{"publicId":"2755619","version":"1","preferredName":"Within 3 months prior to study entry, patient must have a baseline left ventricular ejection fraction (LVEF) measured by MUGA scan >= 55","longName":"2755619","preferredDefinition":"Within 3 months prior to study entry, patient must have a baseline left ventricular ejection fraction (LVEF) measured by MUGA scan >= 55","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC611AC-7BB3-2318-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EC496F3-6DA9-083F-E044-0003BA3F9857","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"CAMPBELB","dateModified":"2008-06-03","deletedIndicator":"No"},{"value":"Patient must be female and 18 years of age or older","valueDescription":"Patient must be female and 18 years of age or older","ValueMeaning":{"publicId":"2755611","version":"1","preferredName":"Patient must be female and 18 years of age or older","longName":"2755611","preferredDefinition":"Patient must be female and 18 years of age or older","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC49E7A-52A7-0C9E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EC4ABD8-3FB8-0D7C-E044-0003BA3F9857","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"ONEDATA","dateModified":"2008-06-03","deletedIndicator":"No"},{"value":"Patient must have an ECOG/ Zubrod performance status of <= 1","valueDescription":"Patient must have an ECOG/ Zubrod performance status of <= 1","ValueMeaning":{"publicId":"2755612","version":"1","preferredName":"Patient must have an ECOG/ Zubrod performance status of <= 1","longName":"2755612","preferredDefinition":"Patient must have an ECOG/ Zubrod performance status of <= 1","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC499A5-4505-0BAA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EC4ABD8-3FCA-0D7C-E044-0003BA3F9857","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"ONEDATA","dateModified":"2008-06-03","deletedIndicator":"No"},{"value":"Diagnosis of invasive adenocarcinoma of breast must have been made by core needle biopsy","valueDescription":"Diagnosis of invasive adenocarcinoma of breast must have been made by core needle biopsy","ValueMeaning":{"publicId":"2755613","version":"1","preferredName":"Diagnosis of invasive adenocarcinoma of breast must have been made by core needle biopsy","longName":"2755613","preferredDefinition":"Diagnosis of invasive adenocarcinoma of breast must have been made by core needle biopsy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC4A6E7-2AAF-72B0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EC4ABD8-3FDC-0D7C-E044-0003BA3F9857","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"ONEDATA","dateModified":"2008-06-03","deletedIndicator":"No"},{"value":"Breast tumor must be palpable and measure >= 2 cm according to RECIST criterion","valueDescription":"Breast tumor must be palpable and measure >= 2 cm according to RECIST criterion","ValueMeaning":{"publicId":"2755614","version":"1","preferredName":"Breast tumor must be palpable and measure >= 2 cm according to RECIST criterion","longName":"2755614","preferredDefinition":"Breast tumor must be palpable and measure >= 2 cm according to RECIST criterion","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC49E7A-52B7-0C9E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EC4ABD8-3FEE-0D7C-E044-0003BA3F9857","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"ONEDATA","dateModified":"2008-06-03","deletedIndicator":"No"},{"value":"Breast cancer must be determined to be HER2-positive prior to study entry","valueDescription":"Breast cancer must be determined to be HER2-positive prior to study entry","ValueMeaning":{"publicId":"2755615","version":"1","preferredName":"Breast cancer must be determined to be HER2-positive prior to study entry","longName":"2755615","preferredDefinition":"Breast cancer must be determined to be HER2-positive prior to study entry","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC4A6E7-2ABF-72B0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EC4ABD8-4000-0D7C-E044-0003BA3F9857","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"ONEDATA","dateModified":"2008-06-03","deletedIndicator":"No"},{"value":"ANC must be <= 1200/mm^3","valueDescription":"ANC must be <= 1200/mm^3","ValueMeaning":{"publicId":"2755624","version":"1","preferredName":"ANC must be <= 1200/mm^3","longName":"2755624","preferredDefinition":"ANC must be <= 1200/mm^3","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC61B22-E8E5-242F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EC61695-6039-23EB-E044-0003BA3F9857","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"ONEDATA","dateModified":"2008-06-03","deletedIndicator":"No"},{"value":"Platelet count must be >=100,000/mm^3","valueDescription":"Platelet count must be >=100,000 /mm^3","ValueMeaning":{"publicId":"2755623","version":"1","preferredName":"Platelet count must be >=100,000 /mm^3","longName":"2755623","preferredDefinition":"Platelet count must be >=100,000 /mm^3","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC619B1-93AF-23E9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EC61695-604B-23EB-E044-0003BA3F9857","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"ONEDATA","dateModified":"2008-06-03","deletedIndicator":"No"},{"value":"Total bilirubin must be <= ULN for the lab","valueDescription":"Total bilirubin must be <= ULN for the lab","ValueMeaning":{"publicId":"2755622","version":"1","preferredName":"Total bilirubin must be <= ULN for the lab","longName":"2755622","preferredDefinition":"Total bilirubin must be <= ULN for the lab","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC618AA-69D5-23FB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EC61695-605D-23EB-E044-0003BA3F9857","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"ONEDATA","dateModified":"2008-06-03","deletedIndicator":"No"},{"value":"Alkaline phosphatase must be <= 2.5 x ULN for the lab","valueDescription":"Alkaline phosphatase must be <= 2.5 x ULN for the lab","ValueMeaning":{"publicId":"2755621","version":"1","preferredName":"Alkaline phosphatase must be <= 2.5 x ULN for the lab","longName":"2755621","preferredDefinition":"Alkaline phosphatase must be <= 2.5 x ULN for the lab","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC617B4-9BA7-237E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EC61695-606F-23EB-E044-0003BA3F9857","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"ONEDATA","dateModified":"2008-06-03","deletedIndicator":"No"},{"value":"AST must be <= 1.5 x ULN for the lab","valueDescription":"AST must be <= 1.5 x ULN for the lab","ValueMeaning":{"publicId":"2755620","version":"1","preferredName":"AST must be <= 1.5 x ULN for the lab","longName":"2755620","preferredDefinition":"AST must be <= 1.5 x ULN for the lab","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC61695-6022-23EB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EC61695-6081-23EB-E044-0003BA3F9857","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"ONEDATA","dateModified":"2008-06-03","deletedIndicator":"No"},{"value":"Serum creatinine must be <= ULN for the lab","valueDescription":"Serum creatinine must be <= ULN for the lab","ValueMeaning":{"publicId":"2755626","version":"1","preferredName":"Serum creatinine must be <= ULN for the lab","longName":"2755626","preferredDefinition":"Serum creatinine must be <= ULN for the lab","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC61F5B-479A-2316-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EC62110-33BB-2611-E044-0003BA3F9857","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"ONEDATA","dateModified":"2008-06-03","deletedIndicator":"No"},{"value":"If patient had skeletal pain or alkaline phosphatase > ULN but <= 2.5 x ULN, bone scan must show NO metastatic disease","valueDescription":"If patient had skeletal pain or alkaline phosphatase > ULN but <= 2.5 x ULN, bone scan must show NO metastatic disease","ValueMeaning":{"publicId":"2755627","version":"1","preferredName":"If patient had skeletal pain or alkaline phosphatase > ULN but <= 2.5 x ULN, bone scan must show NO metastatic disease","longName":"2755627","preferredDefinition":"If patient had skeletal pain or alkaline phosphatase > ULN but <= 2.5 x ULN, bone scan must show NO metastatic disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC619B1-93BF-23E9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4EC62110-33CD-2611-E044-0003BA3F9857","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"ONEDATA","dateModified":"2008-06-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC496F3-6D95-083F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"SBR","dateModified":"2008-12-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811954","version":"1","longName":"Eligibility Criteria","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"CRF Text","type":"Preferred Question Text","description":"Inclusion Criteria","url":null,"context":"CTEP"}],"origin":"ACOSOG CRF:American College of Surgeons Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EC499A5-44F3-0BAA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-06-03","modifiedBy":"CAMPBELB","dateModified":"2008-06-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}